Previously, we reported that, in certain human cancer cells, knockdown of DHX9 using RNAi significantly enhanced MYXV replication, suggesting that DHX9 is capable of mediating antiviral functions against MYXV (11). This evidence concerns the gene DHX9 and cancer.